Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Interest Expenses: 2011-2025

Historic Interest Expenses for Aytu Biopharma (AYTU) over the last 12 years, with Jun 2025 value amounting to $3.7 million.

  • Aytu Biopharma's Interest Expenses fell 48.09% to $516,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 32.39%. This contributed to the annual value of $3.7 million for FY2025, which is 26.80% down from last year.
  • Per Aytu Biopharma's latest filing, its Interest Expenses stood at $3.7 million for FY2025, which was down 26.80% from $5.1 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Interest Expenses ranged from a high of $5.1 million in FY2024 and a low of $3.7 million during FY2025.
  • Over the past 3 years, Aytu Biopharma's median Interest Expenses value was $5.0 million (recorded in 2023), while the average stood at $4.6 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first rose by 1.93% in 2024, then fell by 26.80% in 2025.
  • Over the past 3 years, Aytu Biopharma's Interest Expenses (Yearly) stood at $5.0 million in 2023, then rose by 1.93% to $5.1 million in 2024, then decreased by 26.80% to $3.7 million in 2025.